Vivos Therapeutics (NASDAQ:VVOS) vs. Medacta Group (OTCMKTS:MEDGF) Head to Head Analysis

Vivos Therapeutics (NASDAQ:VVOSGet Free Report) and Medacta Group (OTCMKTS:MEDGFGet Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, analyst recommendations, institutional ownership, dividends, profitability, earnings and risk.

Valuation and Earnings

This table compares Vivos Therapeutics and Medacta Group’s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Vivos Therapeutics $16.02 million 0.49 -$23.84 million ($0.71) -0.37
Medacta Group N/A N/A N/A N/A N/A

Medacta Group has lower revenue, but higher earnings than Vivos Therapeutics.


This table compares Vivos Therapeutics and Medacta Group’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Vivos Therapeutics -121.40% -354.65% -133.79%
Medacta Group N/A N/A N/A

Analyst Recommendations

This is a summary of current ratings and recommmendations for Vivos Therapeutics and Medacta Group, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Vivos Therapeutics 0 0 2 0 3.00
Medacta Group 0 1 1 0 2.50

Institutional and Insider Ownership

15.7% of Vivos Therapeutics shares are held by institutional investors. 9.6% of Vivos Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.


Vivos Therapeutics beats Medacta Group on 5 of the 8 factors compared between the two stocks.

About Vivos Therapeutics

(Get Free Report)

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was founded in 2016 and is based in Littleton, Colorado.

About Medacta Group

(Get Free Report)

Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Europe, North America, the Asia-Pacific, and internationally. It offers personalized 3D planning tools for use in hip, knee, shoulder, sports medicine, and spine procedures. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.

Receive News & Ratings for Vivos Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivos Therapeutics and related companies with's FREE daily email newsletter.